News from valeant pharmaceuticals international, inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 01, 2015, 06:00 ET Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd.

Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) ("Valeant") today announced the expiration of the tender offer (the "Offer")...


Mar 27, 2015, 10:09 ET Valeant Pharmaceuticals Closes Offering Of $1.45 Billion Of Common Shares

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today the closing of its previously announced registered offering...


Mar 17, 2015, 09:00 ET Valeant Pharmaceuticals Prices Offering Of $1.45 Billion Of Common Shares

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) has priced its previously announced registered offering of common shares in the...


Mar 16, 2015, 16:01 ET Valeant Pharmaceuticals Announces Offering Of $1.45 Billion Of Common Shares

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that it has filed with the U.S. Securities and Exchange...


Mar 16, 2015, 08:00 ET Valeant And Salix Agree On Amended Terms To Merger Agreement

- $173 PER SHARE CASH OFFER THROUGH APRIL 7TH - TRANSACTION EXPECTED TO CLOSE APRIL 1ST  Valeant Pharmaceuticals International,...


Mar 13, 2015, 15:48 ET Valeant Announces HSR Clearance For Salix Acquisition

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that it has received early...


Mar 13, 2015, 09:26 ET Valeant Announces Pricing Of Private Offering Of Senior Notes

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) ("Valeant" or the "Company") announced today that VRX Escrow Corp., a newly...


Mar 11, 2015, 18:10 ET Valeant Comments On Endo Offer To Acquire Salix

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today issued the below statement in response to Endo International PLC's...


Mar 11, 2015, 14:28 ET Endo Confirms Proposal To Acquire Salix For $175.00 Per Share In Cash And Stock

 Endo International plc (NASDAQ: ENDP) (TSX: ENL) today confirmed that it has submitted a proposal to the Board of Directors of Salix to...


Mar 09, 2015, 16:40 ET Valeant Announces Launch Of Private Offering Of Senior Notes

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announced today that VRX Escrow Corp., a newly formed wholly owned Canadian...


Feb 25, 2015, 08:00 ET PROVENGE® (sipuleucel-T) Demonstrates Sustained Immune Response Two Years after Treatment in Biochemically-Recurrent Prostate Cancer

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the presentation of new long-term, preliminary results...


Feb 24, 2015, 10:54 ET WeissLaw LLP: Salix Pharmaceuticals Ltd. Acquisition By Valeant Pharmaceuticals International, Inc. May Not Be In The Best Interest of SLXP Shareholders

 The fairness of the proposed acquisition of Salix Pharmaceuticals Ltd. ("SLXP" or the "Company") by Valeant Pharmaceuticals International,...


Feb 23, 2015, 15:16 ET Robbins Arroyo LLP: Acquisition of Salix Pharmaceuticals Ltd. (SLXP) by Valeant Pharmaceuticals International, Inc. (VRX) May Not Be in Shareholders' Best Interests

 Shareholder rights attorneys at Robbins Arroyo LLP are investigating the proposed acquisition of Salix Pharmaceuticals Ltd. (NASDAQ: SLXP) by...


Feb 23, 2015, 14:13 ET SALIX PHARMACEUTICALS, LTD. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Rigrodsky & Long, P.A.: - Do you own shares of Salix Pharmaceuticals, Ltd. (NASDAQ GS: SLXP)? - Did you purchase any of your...


Feb 23, 2015, 13:57 ET Salix Pharmaceuticals, Ltd. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By Valeant Pharmaceuticals International, Inc.

Bernstein Liebhard LLP is investigating whether the Board of Directors of Salix Pharmaceuticals, Ltd. ("Salix" or the "Company") (NASDAQ: SLXP)...


Feb 23, 2015, 09:56 ET Wolf Popper LLP Investigates Claims That the Proposed Acquisition of Salix Pharmaceuticals, Ltd. May Not Be In the Best Interests of Its Investors

Wolf Popper LLP is investigating claims on behalf of investors in Salix Pharmaceuticals, Ltd. ("Salix") (Nasdaq: SLXP), concerning the proposed...


Feb 22, 2015, 16:00 ET Valeant To Acquire Salix Pharmaceuticals For $158.00 Per Share In Cash

- Salix is the Leader in the Growing U.S. Gastrointestinal Market - Transaction Creates a New Specialty Platform for Growth -...


Feb 22, 2015, 16:00 ET Valeant Pharmaceuticals Reports Fourth Quarter And Full Year 2014 Financial Results

2014 Fourth Quarter Results - Total revenue $2.3 billion; an increase of 10% over the prior year despite negative foreign exchange impact...


Feb 10, 2015, 17:15 ET Valeant Pharmaceuticals Announces Expiration Of Bid Deadline In Connection With Agreement To Acquire Assets From Dendreon

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that they have been advised by Dendreon Corporation that no...


Feb 05, 2015, 10:30 ET Valeant Enters Into Amended Agreement To Remain Lead Bidder In Acquisition Of Dendreon And Its Leading Immunotherapy Treatment, PROVENGE® (sipuleucel-T)

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that yesterday it entered into an amended and restated...